Bill Ackman Accuses Herbalife Of False Medical Claims

Bill Ackman’s Pershing Square Capital on Thursday unleashed its latest attack on Herbalife Ltd HLF 1.02%. This time, Ackman’s accusations come in the form of a press release and accompanying video that was posted on Pershing’s anti-Herbalife website. The Claims In the video, Pershing Square argues that Herbalife distributors have been making false and unverified claims about the health…

More Price Target Cuts For Battered Gaming Stocks

Analysts at FBR Capital Markets issued the latest round of price target cuts for casino operators with heavy exposure to the Macau market. Analysts cited declining Macau gaming revenues in November and the first week of December as justification for the cuts. The Cuts FBR cut its price target for Las Vegas Sands Corp LVS 1.12% by $7 per…

A Technical And Fundamental Look At Wal-Mart

Looking at a chart of Wal-Mart Stores, Inc. WMT 1.53% over the past 20 years, it’s hard to argue that it hasn’t been a spectacular investment. The stock has gained nearly 700 percent since the beginning of 1995, more than double the return of the S&P 500 during that span. But with the emergence of fierce online competition…

This Closed-End Fund Can Reduce The Risks Of Investing In China

Many American investors recognize the potential of the rapidly-maturing Chinese economy. Despite China’s GDP growth slowing to about 7.1 percent in 2015, the U.S. economy has nowhere near the long-term growth potential that China does. However, American investors are cautious about putting too much money into Chinese companies when they have no idea what might…

The Biotech Stock With The Most Upside In 2015, According To Morgan Stanley

In its recent annual Big Debates report, Morgan Stanley named Biogen Idec Inc BIIB 2.39% as its top large-cap biotech stock pick for 2015. Analysts are impressed with Biogen’s robust drug pipeline and feel that very little of the company’s potential is currently priced into the stock. The Pipeline Analysts see at least five drugs in Biogen’s pipeline that could contribute to…

Morgan Stanley Sees A Shiny Opportunity In This Metal

A recent report by Morgan Stanley makes the case for a 30 percent upside in aluminum stocks. Analysts believe that an increasing demand for aluminum from the auto and aerospace industries combined with a slowdown in worldwide production growth will create a strong opportunity for U.S. aluminum companies. Demand Analysts see the biggest upcoming new demand for…

Morgan Stanley Sees Key Opportunities In European Banks

A recent Morgan Stanley report indicates that analysts believe that there is opportunity for selective investors in the European banking sector. The report centers around dividends as the bellwether for health among banks. Morgan Stanley sees the potential for a handful of European banks to boost dividend payments by 2016, while other banks are at risk of…

Will Oil Be The Best Investment Of 2015?

Bank of America analysts believe 2015 may be the time for investors to start dipping their toes into oil again. In a recent report, analysts presented the case for cautiously venturing into oil-exposed energy stocks that have heavily underperformed in 2014 due to the collapse in oil prices.